FDA and outliers [Study As­sess­ment]

posted by mittyri – Russia, 2018-12-11 16:38 (1015 d 20:14 ago) – Posting: # 19681
Views: 6,171

Dear Mann,

I don't think the position of FDA is different.
Please see this old post.

Do you have any experience of BEQ analysis for submission in FDA/EMA jurisdiction?
Where is the idea of outliers coming from?
Do the results without any outliers analysis also show not-BE?

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,691 posts in 4,534 threads, 1,541 registered users;
online 6 (0 registered, 6 guests [including 3 identified bots]).
Forum time: Wednesday 13:53 CEST (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5